請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30081
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃孝平(Hsiao-Ping Huang) | |
dc.contributor.author | Yung-Lun Chen | en |
dc.contributor.author | 陳永論 | zh_TW |
dc.date.accessioned | 2021-06-13T01:34:55Z | - |
dc.date.available | 2009-07-26 | |
dc.date.copyright | 2007-07-26 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-14 | |
dc.identifier.citation | [中 文]
[1] 張智星,「MATLAB 程式設計與應用」,清蔚科技,新竹 市,(2000) [英 文] [2] A. Makroglou, Jiaxu Li, Yang Kuang” Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview”Applied Numerical Mathematics vol.56,pp 559–573 (2006) [3] A. Ackerman, C. Gatewood, J. W. Rosevear, and G. D. Molnar, “Model studies of blood glucose regulation” Bull. Math. Biophys., vol.27, pp. 21-37 (1965) [4] A. Albisser. “An artificial endocrine pancreas “, Diabetes, vol.23, pp.389-404 (1974). [5] A. H. Clements, P. H. Chang, and R.W. Meyer, “The development of biostator, a glucose controlled insulin infusion system”, Horm. Metab. Res. vol.9, pp.23-33 (1977) [6] C. Cobelli, A. Caumo, P. Vicini, J.Z. Jeffrey, A. Angelo, Y. Kevin, M. B. Dennis’ Undermodeling affects minimal model indexes: insights from a two-compartment model’ Am J Physiol Endocrinol Metab.vol. 276,pp.1171-1193, (1999) [7] C. Cobelli, G. Pacini, G. Toffolo, and L. Sacca ‘Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT’ Am J Physiol Endocrinol Metab, pp.E591~E598 (1986) [8] B. Candas, J. Radziuk, “An adaptive plasma glucose controller based on a nonlinear insulin/glucose model”, IEEE Trans Biomed Eng. vol.41(2) pp.116-24 (1994) [9] J.F. Casanova Domingo, R. Ruiz, F. Aldana, M. Serrano-Rios,’Adaptation drift suppression in blood glucose self-tuning control”, Artif Organs. Apr ;21(4):272-277 (1991) [10] F. Chiarelli, S. Tumini, G. Morgese, A.M. Albisser,“Controlled study in diabetic children comparing insulin-dosage adjustment by manual and computer algorithms”, Diabetes Care. Oct; vol.13(10),pp.1080-1084.(1990) [11] M. E. Fisher,“A semiclosed-loop algorithm for the control of blood glucose levels in diabetics”, IEEE Trans Biomed Eng. Jan; vol.38(1),pp.57-61.(1991) [12] T. E. Guttinger, M. Morari, “Predicting Multiple Steady States in Equilibrium Reactive Distillation. 1. Analysis of Nonhybrid Systems.” Ind. Eng. Chem. Res., vol.38(4),pp.1633 (1999). [13] G. Marchetti, M. Barolo, L. Jovanovic, H. Zisser, and Dale E. Seborg, “An Improved PID Switching Control Strategy for Type-1 Diabetes” IEEE EMBS Annual Int. Conf [14] G. Schlotthauer, G.A. Nicolini, L.G. Gamero, M.E. Torres,” Type-1 Diabetes: Modeling, Identification, Non-linear model predict control” IEEE Trans Biomed Eng. vol.33, pp.2261-2271,(2002) [15] H. Zisser, L. Jovanovic, F. Doyle, P. Ospina, and C. Owens, “Run–to–run control of meal–related insulin dosing,” Diabetes Technol Ther, vol. 7, no. 1, pp. 48–57,(2005) [16] Jiaxu Li,Yang Kuang,Clinton C. Mason;” Modeling the glucose–insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays” Journal of Theoretical Biology.vol.242, pp.722–735 (2006) [17] S. Kan, H. Onodera, E. Furutani, T. Aung, M. Araki, H. Nishimura, S. Maetani, M. Imamura., ”Novel control system for blood glucose using a model predictive method”, ASAIO J. Nov-Dec;vol.46(6),pp.657-62.(2000) [18] K.H. Kienitz, T. Yoneyama,“A robust controller for insulin pumps based on H-infinity theory”, IEEE Trans Biomed Eng. vol;40(11),pp.1133 (1993) [19] L.C. Gatewood, Ackerman E., J. W. Rosevear,, G. D. Molnar, “Test of Mathematical model of the blood-glucose regulatory system”, Comput. Biol. Med., vol.2, pp. 1-14, (1968) [20] L.C. Gatewood, Ackerman E., J. W. Rosevear,, G. D. Molnar, ” Simulation studies of blood-glucose regulation: Effect of intestinal glucose absorption”. Comput. Biol. Med., vol.2, pp.15-27 (1968) [21] E. W. Malgorzata, J. C. Ludovic, C. S. Helga, S. Lukas, R.P. Thomas, and R. Hovorka;” Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin” IEEE. Trans. On Biomedical Enginering, vol.52, No.1, January (2005) [22] E. F. Michael and L. T. Kok, “Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE. Trans. On Biomedical Enginering, vol. 36, no.4. pp.479-486,(1989) [23] T.F. Pfeiffer, C. Thum, and A.H. Clements, “The artificial beta cell—a continuous control of blood sugar be external regulation of insulin infusion, Horm. Metab. Res. Vol.6, pp. 339-342, (1974) [24] P. Palazzo, V. Viti, ”A new glucose-clamp algorithm--theoretical considerations and computer simulations”, IEEE Trans Biomed Eng. vol.37(5),pp.535-543 (1990) [25] R. Bellazzi, G. Nucci, C. Cobelli,“The subcutaneous route to insulin - dependent diabetes therapy”IEEE Eng. Med. Biol. Mag. vol.20(1) pp.54~64. (2001) [26] G..P. Reboldi, P.D. Home, G.. Calabrese, P.G. Fabietti, Brunetti, P. Massi. M. Benedetti., ‘Time delay compensation for closed-loop insulin delivery systems: a simulation study”, Int J Artif Organs. Jun; vol.14(6),pp.350-358. (1991) [27] R. Hovorka,“Management of diabetes using adaptive control” Int. J. Adapt. Control Signal Process. vol.9(5), pp.309~325.(2005) [28] R. Hovorka, F. Shojee-Moradie, P.V. Carroll,” Partitioning glucose distribution/transport, disposal ,and endogenous production during IVGTT ”Am J Physiol Endocrinol Metab vol.282.pp.992-1007,( 2002) [29] Roman Hovorka, Valentina Canonico, Ludovic J Chassin, Ulrich Haueter, Massimo Massi-Benedetti, Marco Orsini Federici, Thomas R Pieber, Helga C Schaller, Lukas Schaupp, Thomas Vering and Malgorzata EWilinska;” Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes” Physiol. Meas.vol.25,pp.905–920(2004) [30] R. Hovorka, L. J. Chassin, M. E. Wilinska, V. Canonico, J. A. Akwi, M. O. Federici, M. Massi-Benedetti, I. Hutzli, C. Zaugg, H. Kaufmann, M. Both, T. Vering, H. C. Schaller, L. Schaupp, M. Bodenlenz, T. R. Pieber, Closing the loop: the ADICOL experience, Diabetes Technol Ther vol.6(3),pp.307-318. (2004) [31] R. Hovorka.”Continuous glucose monitoring and closed-loop systems ” Diabet Med vol.23 pp.1-12.(2006) [32] R. N. Bergman, C. R. Bowden, C. Cobelli,” The minimal model approach to quanti-cation of factors controlling glucose disposal in man ”in: C. Cobelli, R. N. Bergman (Eds.), Carbohydrate Metabolism, John Wiley & Sons Ltd., Ch. 13, pp. 269-293.(1981) [33] R. N. Bergman, Finegood, D.T., Ader, M.,” Assessment of insulin sensitivity in vivo ”. Endocr. Rev. 6, 45–86.(1985) [34] R. N. Bergman,” The minimal model: yesterday, today, and tomorrow, in: The minimal model approach and determinants of glucose tolerance ”, Vol. 7 of Pennington Center Nutrition Series, Louisiana State University Press, Baton Rouge, LA, pp. 3-50.(1997) [35] R. N. Bergman, “ Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology “. Irving L. Schwartz Lecture, Mount Sinai J. Med. Vol.60,pp.280–290.(2002) [36] R. N. Bergman, Finegood, D.T., Kahn, S.E., The evolution of betacell dysfunction and insulin resistance in type 2 diabetes. Eur. J. Clin. Invest.vol. 32 (Suppl. 3), pp.35–45.( 2002) [37] R. S. Parker, F. J. Doyle III, N. A. Peppas, “The intravenous route to blood glucose control” IEEE Eng. Med. Biol. Mag. vol.20 (1), pp.65~73. (2001) [38] R. S. Parker, F. J. Doyle, III, N. A. Peppas, “ A model-based algorithm for blood glucose control in type I diabetic patients ” IEEE Trans. Biomed. Eng. vol.46 (2), pp.148-157. (1999) [39] S.Kirkpatrick, C.D.Gelatt,“M.P.Vecchi. Optimization by Simulated Annealing”. Science 13 May, vol. 220, Number 4598,(1983) [40] S. M. Lynch, B. W. Bequette, “ Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements ” in: Proceedings of the American Control Conference, pp. 4039-4043. (2002) [41] R.F. Stengel, Optimal Control and Estimation. Dover Publications: New York, (1994) (originally published as Stochastic Optimal Control: Theory and Application. Wiley) [42] J. Sturis , K.S. Polonsky , E. Mosekilde , E. Van Cauter, Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am. J. Physiol. 260, E801–E809.(1991) [43] T. Yipintsoi, L.C. Gatewood, E. Ackerman, P.L., Spivak, G. D. Molnar, G. W. Rosevear, and F.C. Service, “Mathematical analysis of blood glucose and plasma insulin responses to insulin infusion in healthy and diabetes subjects”, Comput. Biol. Med., vol.3, pp.71-78, (1973) [44] J. T. Sorensen, “A Physiologic Model of Glucose Metabolism in Man and its Use to Design and Assess Improved Insulin Therapies for Diabetes,” PhD Thesis, Dept. of Chemical Engineering. MIT (1985). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30081 | - |
dc.description.abstract | 第一型糖尿病患者必依賴外加胰島素的注射來控制血糖濃度以維持生命。血糖之控制良窳,攸關許多併發症之發生機率。因此血糖控制至為重要。 最近在血糖監測硬體方面已有連續血糖監測器(CGMS)之問世,提供病患更為詳細的血糖監測。本研究主旨即在於以CGMS為工具探討此類病人體內血糖之動態模式以及相對之血糖控制方式。首先,透過連續性血糖量測器(CGMS) 記錄病人血糖之連續變化。 然後,針對Jiaxu Li et al.(2006) 及Hovorka et al.(2005)所提出的兩種第一型糖尿病模型略作修改,透過記錄之臨床數據建立屬於病人的血糖動態模型。確定了病人模型後,即據以研擬胰島素之用量方式,並與實際情形比對以檢驗兩種模型之可行性。本研究同時將提供量化及系統化的血糖控製策略供醫生參考,以提高用藥之效率。第一種控制策略為一般病患常用的Bolus加上基本胰島素注射來控制體內血糖,第二種控制策略則以單餐為基準,透過最適化策略來決定一套胰島素施打的方式。文中將比較此兩種控制策略下,體內血糖的變化,並討論其優劣。 | zh_TW |
dc.description.abstract | People with type 1 diabetes must rely on exogenous insulin for survival. A good control of blood glucose will substantially reduce the possibility of complication. In this research, modeling the blood glucose using the clinical data of a type-1 patient from a continuous glucose monitoring system (CGMS) is studied. Two models, DDE model of Jiaxu Li (2006) and physiological model of Hovorka (2006) are considered for this modeling of blood glucose. Appraisal of the results from the two models is made. The appraisal includes its ability to estimate the amounts of insulin needed for basal and bolus injections, its ability to predict the future blood glucose, and its sensitivity to detect hypoglycemia and hyperglycemia. The basal and bolus injections mentioned are aimed to maintaining a fasting blood glucose and a postprandial blood glucose within a reasonable range, respectively. Control strategies for patients that use continuous subcutaneous infusions via an insulin pump or discontinuous subcutaneous basal and bolus injections are presented. Comparisons between these two strategies in terms of blood glucose and insulin dosage are also made. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T01:34:55Z (GMT). No. of bitstreams: 1 ntu-96-R94524087-1.pdf: 3204607 bytes, checksum: ac1488e3f3e6a49f957d6f70a89fcdca (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 摘要....................... ...........................I
Abstract.......... ....................................II 目錄.............. ....................................III 圖索引............ ....................................IV 表索引............ ....................................VII 1.緒論................................................ 1 1.1 前言.......... .....................................1 1.2 文獻回顧...........................................2 1.3 研究動機與目的 .....................................6 1.4 組織章節.......................................... 7 2.第一型糖尿病模型之回顧... ............................8 2.1 體內醣類的代謝 .....................................8 2.2第一型糖尿病血糖模式之回顧..........................10 3.模型修改及驗證...................................... 26 3.1 糖尿病血糖DDE模式之修改............................26 3.1.1 DDE模式回歸結果-進食血糖消化之速率以脈衝函數表示 27 3.1.2 DDE模式回歸結果-進食血糖消化之速率以指數函數表示 32 3.1.3 DDE模式兩種進食項修正下模擬結果之比較........... 37 3.2 Hovorka模型之增補................................. 43 3.3 結果討論:......................................... 54 4.極大值原理.......................................... 56 5.血糖控制策略........................................ 64 5.1 Bolus的應用在此模式中的探討....................... 64 5.2控制策略(1): Bolus及基本胰島素注射................. 65 5.3 控制策略(2): 最適化控制策略....................... 66 5.4 設定點之修改...................................... 68 5.5 結果討論(1)....................................... 78 6. 結論............................................... 83 A.附錄................................................ 85 B.附錄................................................ 93 參考文獻.............................................. 99 | |
dc.language.iso | zh-TW | |
dc.title | 第ㄧ型糖尿病之血糖動態模式與胰島素用藥策略研究 | zh_TW |
dc.title | Dynamic Models and Open-Loop Control of Blood-Glucose for Type 1 Diabetes Mellitus | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳誠亮(Cheng-Liang Chen),周宜雄(Yi-Shyong Chou),王國彬(Gow-Bin Wang),陳榮輝(Jung-hui Chen) | |
dc.subject.keyword | 血糖,胰島素,第一型糖尿病,最適化控制, | zh_TW |
dc.subject.keyword | blood glucose,insulin,type 1 diabetes,optimal control, | en |
dc.relation.page | 104 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-16 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
顯示於系所單位: | 化學工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 3.13 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。